4//SEC Filing
VIROPHARMA INC 4
Accession 0001127602-14-002336
CIK 0000946840operating
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 11:44 AM ET
Size
41.8 KB
Accession
0001127602-14-002336
Insider Transaction Report
Form 4
VIROPHARMA INCVPHM
Wolf John Peter III
VP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2014-01-17$19.73/sh+9,000$177,570→ 61,983 total - Exercise/Conversion
Common Stock
2014-01-17$8.71/sh+6,949$60,526→ 68,932 total - Exercise/Conversion
Common Stock
2014-01-17$15.24/sh+4,452$67,848→ 73,384 total - Exercise/Conversion
Common Stock
2014-01-17$13.97/sh+2,500$34,925→ 75,884 total - Exercise/Conversion
Common Stock
2014-01-17$13.50/sh+6,000$81,000→ 88,836 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−4,452→ 0 totalExercise: $15.24From: 2007-01-12Exp: 2017-01-12→ Common Stock (4,452 underlying) - Exercise/Conversion
Common Stock
2014-01-17$7.05/sh+12,000$84,600→ 52,983 total - Exercise/Conversion
Common Stock
2014-01-17$9.99/sh+6,952$69,450→ 82,836 total - Exercise/Conversion
Common Stock
2014-01-17$5.91/sh+4,000$23,640→ 92,836 total - Exercise/Conversion
Common Stock
2014-01-17$17.84/sh+2,346$41,853→ 110,768 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−9,000→ 0 totalExercise: $19.73From: 2007-01-17Exp: 2016-01-17→ Common Stock (9,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−2,500→ 0 totalExercise: $13.97From: 2008-06-15Exp: 2017-06-15→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2014-01-17$8.86/sh+9,336$82,717→ 102,172 total - Exercise/Conversion
Common Stock
2014-01-17$11.31/sh+6,250$70,688→ 108,422 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−12,000→ 0 totalExercise: $7.05From: 2006-06-21Exp: 2015-06-21→ Common Stock (12,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−6,949→ 0 totalExercise: $8.71From: 2007-08-03Exp: 2016-08-03→ Common Stock (6,949 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−6,000→ 0 totalExercise: $13.50From: 2010-01-08Exp: 2019-01-08→ Common Stock (6,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−9,336→ 0 totalExercise: $8.86From: 2011-01-07Exp: 2020-01-07→ Common Stock (9,336 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−6,250→ 0 totalExercise: $11.31From: 2011-06-07Exp: 2020-06-07→ Common Stock (6,250 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−6,952→ 0 totalExercise: $9.99From: 2009-06-13Exp: 2018-06-13→ Common Stock (6,952 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−4,000→ 0 totalExercise: $5.91From: 2010-06-11Exp: 2019-06-11→ Common Stock (4,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-01-17−2,346→ 18,059 totalExercise: $17.84From: 2012-01-05Exp: 2021-01-05→ Common Stock (2,346 underlying)
Footnotes (1)
- [F1]The options vest in four equal annual installments beginning on the anniversary date from time of grant.
Documents
Issuer
VIROPHARMA INC
CIK 0000946840
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000946840
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 11:44 AM ET
- Size
- 41.8 KB